ReviewReviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis
Introduction
IPF is one of the most pernicious and enigmatic form of lung fibrogenesis, the average survival time is about two to three years after diagnosis in affected patients [1]. Although some autoimmune diseases (e.g. rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis), genetic variants (e.g. MUC5B, VEGFA and TGF-b) and environment factors (e.g. viral infection, aging) have been reported to be risk factors of IPF, but the pathogenesis of this disorder is not fully understood [2].
Previous studies reported that IPF was characterized by continuous alveolar epithelium microinjuries and hyperplasia [3]. Injured epithelium could release growth factors, cytokines and matrix metalloproteinase, which caused the activation/proliferation of mesenchymal cell, deposition of extracellular matrix and the accumulation of fibroblasts. Next it may lead to basal membrane disruption, fibrin formation, abnormal wound repair and angiogenesis [4].
During those processes, several signaling pathways were activated to transmit important regulation signals to cell apoptosis, survival, migration or communication (see Table 1), such as transforming growth factor-beta (TGF-β) [5], wnt [6], vascular endothelial growth factor (VEGF) [7] and phosphoinositide 3-kinase (PI3K–Akt) [8], [9]. Therefore, many attentions had focused on the functions of disease related signaling pathways in IPF pathological research [9], [10]. Here, we summarized the signaling pathways which were reported to be key players in the pathogenesis of fibrosis, including the activation, hyperplasia and accumulation of myofibroblasts, and discussed the potential utility of signal molecules as future treatment targets in IPF.
However, along with the development of experiment technology and especially the implementation of many whole genome sequencing project, the number of disease related genomic data is rapidly increasing [11], [12], [13]. From the aspect of pathway research, the number of disease related signals is generating and the function of disease related signaling pathways is being comprehensive [14]. Whereas traditional pathway analysis has worked on the independent pathogenetic principles of signaling pathway and the independent function of related signal molecules, the crosstalk and interaction between pathways were rarely analyzed [15]. In this review, we discuss the novel integrative analysis prospective from systematic biological approach. In order to better clarify the associations between different signal molecules, and to comprehensively tease out the functional pathway profiles involved in the development and progression of IPF, the integrative analysis of genomic data is powerful and imperative. In the mean time, the comprehensive mapping of the signaling pathways in IPF would be powerful to detect novel early diagnosis marker and therapeutic targets, and give new research perspective on IPF research.
Section snippets
Activated signaling pathways involved in the pathology changes of IPF
In the early pathological alteration of IPF, excessive accumulation of fibroblast and extracellular matrix play key roles in the formation of fibrotic lesion, followed by the formation of a scar [16], [17]. Fibroblastic foci are regions located immediately adjacent to regions of hyperplastic or apoptotic alveolar epithelial cells. Epithelial microinjuries trigger abnormal epithelial–mesenchymal interactions and pathogenesis of idiopathic pulmonary fibrosis. Current phenomenon indicated that the
Pathway analysis of pulmonary fibrosis
Despite the known pathway data involved in the pathology of idiopathic pulmonary fibrosis which were obtained from recently publications, huge amounts of high-throughput information are produced in post-genomic era and the pool of omics data is rapidly growing. Integrated analysis of multiple types of omics data, such as metabolomics, proteomics, transcriptomics, and genomics, yields more information on the biological process than analysis of single type of signaling pathway. Rheumatologists
Integrative analysis of pathways is urgent for IPF
It is noteworthy that integrated analysis of functional genomics and cellular/molecular immunology is the general trend of polygenic diseases, especially on disease related pathway analysis [82], [83], [84]. Despite screening the entire human genome in patients, much more information is needed to tease out the functional profile of genes involved in the development and progression of IPF. During disease related pathway analysis, considering multilevel data from Gene ontology analysis,
Conclusion
With the increase of the experiment and biology data, massive amounts of disease susceptibility genes and mutation sites are explored, and also, IPF related signaling pathways are relatively richer. Systematically combine the wealth of biological resources from multiple levels, and integrated analysis those omics data with signaling pathways, would contribute to the construction of a more comprehensive IPF related signaling pathway database. From the IPF signaling pathway resource, researchers
Take-home messages
- •
Many signaling pathways play key roles in the pathogenesis of IPF.
- •
They regulate the proliferation, differentiation, apoptosis and migration of cells, which contained the epithelium, myofibroblasts and fibroblasts.
- •
Crosstalks and interactions among different signaling pathways are being emphasized.
- •
Integrating biological data from functional genomics and cellular/molecular immunology give a wealth of signaling pathway database.
- •
Systematically analyzing signaling pathways with the massive and
Acknowledgements
This study was supported by grants from the Key Program of National Science and Technology Major Project of China (No. 2012ZX09103301-026) and the National Natural Science Foundation of China (No. 81030058).
References (87)
- et al.
Investigating Wnt signaling: a chemogenomic safari
Drug Discov Today
(11-01-2005) - et al.
VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice
Int Immunopharmacol
(01-01-2009) - et al.
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Lancet
(08-18-2012) - et al.
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
Lancet Respir Med
(06–01–2013) - et al.
Long-range PCR based sequencing of the highly homologous genes, SFTPA1 and SFTPA2
Mol Cell Probes
(06-01-2013) - et al.
Pulmonary fibrosis: pathogenesis, etiology and regulation
Mucosal Immunol
(03-01-2009) - et al.
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Int J Biochem Cell Biol
(01-20-2008) - et al.
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Biochem Biophys Res Commun
(02-02-2007) - et al.
Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment
Clin Immunol
(06-01-2001) - et al.
Beta-catenin signaling in fibroproliferative disease
J Surg Res
(03-01-2007)
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis
Am J Pathol
TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts
Pharmacol Res
Signaling through focal adhesion kinase
Prog Biophys Mol Biol
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis
Adv Drug Deliv Rev
FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis
Am J Pathol
Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway
Exp Cell Res
Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts
Biochem Biophys Res Commun
Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta)
J Biol Chem
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
Lung Cancer-J Iaslc
Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis
Am J Pathol
PTEN regulates fibroblast elimination during collagen matrix contraction
J Biol Chem
Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix
Am J Pathol
Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice
Respir Physiol Neurobiol
Integrated enrichment analysis and pathway-centered visualization of metabolomics, proteomics, transcriptomics, and genomics data by using the InCroMAP software
J Chromatogr B Analyt Technol Biomed Life Sci
Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy
Autoimmun Rev
Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-beta signaling pathway
J Biol Chem
Identification and characterization of two novel brain-derived immunoglobulin superfamily members with a unique structural organization
Mol Cell Neurosci
Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Eur Respir J
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy
Pharm Res
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy
Ann Intern Med
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
Respir Res
The impact of TGF-beta on lung fibrosis: from targeting to biomarkers
Proc Am Thorac Soc
Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF)
J Recept Signal Transduct Res
Signaling pathways in the epithelial origins of pulmonary fibrosis
Cell Cycle
Evolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genes
Clin Transl Sci
Transcriptome analysis reveals differential splicing events in IPF lung tissue
PLoS One
Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway
Eur Respir J
Idiopathic pulmonary fibrosis
Orphanet J Rare Dis
Peripheral blood fibrocytes: differentiation pathway and migration to wound sites
J Immunol
TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
Am J Physiol Lung Cell Mol Physiol
Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse
Respir Res
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
Proc Natl Acad Sci U S A
TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)
Respir Res
Cited by (69)
Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics
2023, European Journal of Pharmaceutics and BiopharmaceuticsPDCD6 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis through the AKT/GSK3β/β-catenin Pathway
2023, Biomedical and Environmental SciencesThymol protects against bleomycin-induced pulmonary fibrosis via abrogation of oxidative stress, inflammation, and modulation of miR-29a/TGF-β and PI3K/Akt signaling in mice
2023, Life SciencesCitation Excerpt :Importantly, THY previously targeted this pathway to prevent the cellular proliferation and invasion of bladder cancer and colorectal adenocarcinoma [54,55]. In addition to the prominent role of PI3K/Akt pathway in the fibrosis process, particularly in IPF, other molecular signaling components such as TGF-β, Wnt/β-catenin, and vascular endothelial growth factor (VEGF) were found to be involved in fibrosis [56]. Remarkably, THY effectively targeted those critical pathways in different disease models.
Synthesis and biological evaluation of 4-(pyridine-4-oxy)-3-(tetrahydro-2H-pyran-4-yl)-pyrazole derivatives as novel, potent of ALK5 receptor inhibitors
2022, Bioorganic and Medicinal Chemistry LettersSignaling pathways promoting epithelial mesenchymal transition in oral submucous fibrosis and oral squamous cell carcinoma
2020, Japanese Dental Science ReviewSynthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors
2020, European Journal of Medicinal Chemistry